Literature DB >> 6739339

Cerebrospinal fluid shunt infections.

J D Nelson.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6739339     DOI： 10.1097/00006454-198405001-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN： 0277-9730


× No keyword cloud information.
  11 in total

1.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

Review 2.  Neuroimaging of ventriculoperitoneal shunt complications in children.

Authors:  Ahilan Sivaganesan; Rajesh Krishnamurthy; Deshdeepak Sahni; Chitra Viswanathan
Journal:  Pediatr Radiol       Date:  2012-06-28

3.  Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional cerebrospinal fluid (CSF) cultures among children undergoing treatment for CSF shunt infection.

Authors:  Tamara D Simon; Brian Van Yserloo; Kevin Nelson; David Gillespie; Randy Jensen; James P McAllister; Jay Riva-Cambrin; Chris Stockmann; Judy A Daly; Anne J Blaschke
Journal:  Diagn Microbiol Infect Dis       Date:  2013-08-13       Impact factor: 2.803

4.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

5.  Reinfection following initial cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Matthew Hall; J Michael Dean; John R W Kestle; Jay Riva-Cambrin
Journal:  J Neurosurg Pediatr       Date:  2010-09       Impact factor: 2.375

6.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

7.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

8.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

9.  The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections.

Authors:  M J Rieder; T C Frewen; R F Del Maestro; A Coyle; S Lovell
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262

10.  Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.

Authors:  Tamara D Simon; Matthew Hall; Jay Riva-Cambrin; J Elaine Albert; Howard E Jeffries; Bonnie Lafleur; J Michael Dean; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-08       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.